Journal of Ophthalmology

Research Article

Clinical Presentations and Outcomes of Retinoblastoma Patients in relation to the Advent of New Multimodal Treatments: A 12-Year Report from Single Tertiary Referral Institute in Thailand

Table 2

Treatment modalities and globe salvage rates for intraocular tumor according to International Classification of Retinoblastoma (ICRB).
Treatment modalities, n = 115ICRB group, eyes (globe salvage, %)
ABCDE
UnilateralBilateralUnilateralBilateralUnilateralBilateralUnilateralBilateralUnilateralBilateral
CRD—4 (100%)1 (100%)9 (100%)—2 (100%)—9 (66.7%)2 (0%)19 (47.4%)
CRD + plaque———2 (100%)1 (100%)———— 
CRD + EBRT———1 (100%)———1 (0%)— 
CRD + IAC———2 (100%)—1 (100%)4 (75%)4 (100%)3 (0%)6 (33.3%)
CRD + IAC + IVT———1 (100%)—2 (100%)1 (100%)—— 
CRD + IAC + plaque——————4 (75%)1 (0%)— 
CRD + IVT + plaque———2 (50%)————— 
CRD + IAC + IVT + plaque———1 (100%)——1 (0%)—— 
IAC——————1 (0%)1 (100%)3 (67.7%)1 (0%)
IAC + IVT————————1 (100%) 
IAC + IVT + plaque——————1 (0%)—  
Primary enucleation (in our center/from referral hospital)——————2 (1/1)1 (0/1)7 (7/0)13 (8/5)
Secondary enucleation (in our center/from referral hospital)———1——5 (5/0)5 (5/0)6 (6/0)15 (14/1)
Total04 (100%)1 (100%)18 (94.4%)1 (100%)5 (100%)14 (50%)17 (64.7%)16 (18.8%)39 (28.2%)
ICRB = International Classification of Retinoblastoma; CRD = chemoreduction; IAC = intra-arterial chemotherapy; EBRT = external beam radiation therapy; IVT = intravitreal chemotherapy.